A sponsor-underwriting guide to private equity in eye care, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, optical and clinical economics, cash conversion, leverage, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
A transaction-focused guide to retina practice M&A, including specialist capacity, injection and procedure mix, buy-and-bill exposure, payer and referral durability, platform demand, diligence, valuation, and seller proceeds.
A sponsor-underwriting guide to private equity in dermatology, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, Mohs and pathology economics, payer and referral durability, cash conversion, leverage, financing, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
A sponsor-underwriting guide to private equity in pain management, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, cash conversion, referral and payer durability, ASC adjacency, controlled-substance and compliance risk, leverage, financing, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
An in-depth guide to how buyers evaluate physical therapy and outpatient rehab practices, from clinic density and clinician productivity to referral durability, reimbursement, EBITDA quality, diligence, and transaction structure.
A sponsor-underwriting guide to private equity in physical therapy, including platform formation, add-on acquisitions, buyer-accepted EBITDA, referral and payer economics, cash conversion, clinician capacity, leverage, value creation, integration, rollover equity, governance, downside and exit cases, and seller proceeds.
A transaction-focused guide to orthopedic practice M&A, including why buyers pursue MSK groups, how they underwrite operating evidence, and what owners can do to protect value and closing certainty.
A buyer-underwriting guide to orthopedic practice acquirers, including strategic healthcare operators, private equity-backed platforms, MSOs, physician-led buyers, buyer fit, physician and ancillary transferability, financing, diligence, offer comparison, closeability, and seller outcomes.
A sponsor-underwriting guide to private equity in orthopedics, including platform formation, add-on acquisitions, buyer-accepted EBITDA, physician and ancillary economics, cash conversion, leverage, value creation, integration, rollover equity, governance, downside and exit cases, and seller proceeds.
By George Barsom, JD, CM&AA®, CAIA® • Last updated: August 17, 2026 Updated August 2026 for fertility-clinic owners, women’s-health operators, private-equity sponsors, lenders, and transaction stakeholders evaluating platform formation, add-on acquisitions, buyer-accepted earnings, IVF laboratory capacity, leverage, rollover equity, governance, diligence, integration, and seller proceeds. Key answer: Private equity sponsors invest in fertility clinics and…